CA3081513C — Prodrugs of fumarates and their use in treating various diseases
Assigned to Alkermes Pharma Ireland Ltd · Expires 2022-06-21 · 4y expired
What this patent protects
The present invention relates to various prodrugs of monomethyl fumarate, which offer improved properties relative to dimethyl fumarate. The invention provides compounds of formula (Ia), and pharmaceutical compositions thereof, which are useful in the treatment of immunological, …
USPTO Abstract
The present invention relates to various prodrugs of monomethyl fumarate, which offer improved properties relative to dimethyl fumarate. The invention provides compounds of formula (Ia), and pharmaceutical compositions thereof, which are useful in the treatment of immunological, autoimmune, and inflammatory diseases and conditions, including multiple sclerosis. (see formula Ia)
Drugs covered by this patent
- Vumerity (DIROXIMEL FUMARATE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.